Thomas Riley

Professor, BAppSc Curtin, MAppEpid ANU, PhD W.Aust., FAAM, FASM, FRCPath, MAIMS

  • The University of Western Australia (M502), 35 Stirling Highway,

    6009 Perth

    Australia

  • 12180 Citations
  • 52 h-Index
1992 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Anaerobic bacteriology
  • Antibiotics
  • Bacteria—antibiotic resistance
  • Bacteria—pathogenesis
  • Clostridium difficile
  • Diagnostic bacteriology
  • Infection control
  • Infectious diseases epidemiology
  • Infectious disease—alternative therapies
  • Infectious disease—animals, humans

Fingerprint Dive into the research topics where Thomas Riley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Clostridium difficile Medicine & Life Sciences
Tea Tree Oil Medicine & Life Sciences
Clostridium Infections Medicine & Life Sciences
Ribotyping Medicine & Life Sciences
Melaleuca Medicine & Life Sciences
Western Australia Medicine & Life Sciences
Polymerase Chain Reaction Medicine & Life Sciences
Volatile Oils Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

3 Citations (Scopus)

An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial

Mitchell, B. G., Hall, L., White, N., Barnett, A. G., Halton, K., Paterson, D. L., Riley, T. V., Gardner, A., Page, K., Farrington, A., Gericke, C. A. & Graves, N., 1 Apr 2019, In : The Lancet Infectious Diseases. 19, 4, p. 410-418 9 p.

Research output: Contribution to journalArticle

Cross Infection
Multicenter Studies
Bacteremia
Infection
Touch
2 Citations (Scopus)

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing Glade 2 ribotype 251 strain

Wehrhahn, M. C., Keighley, C., Kurtovic, J., Knight, D. R., Hong, S., Hutton, M. L., Lyras, D., Wang, Q., Leong, R., Borody, T., Edye, M. & Riley, T. V., Feb 2019, In : Anaerobe. 55, p. 117-123 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies

Tague, A. J., Putsathit, P., Hammer, K. A., Wales, S. M., Knight, D. R., Riley, T. V., Keller, P. A. & Pyne, S. G., 15 Apr 2019, In : European Journal of Medicinal Chemistry. 168, p. 386-404 19 p.

Research output: Contribution to journalArticle

Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model

Tague, A. J., Putsathit, P., Hutton, M. L., Hammer, K. A., Wales, S. M., Knight, D. R., Riley, T. V., Lyras, D., Keller, P. A. & Pyne, S. G., 15 May 2019, In : European Journal of Medicinal Chemistry. 170, p. 203-224 22 p.

Research output: Contribution to journalArticle

Clostridium difficile ribotype 017-characterization, evolution and epidemiology of the dominant strain in Asia

Imwattana, K., Knight, D. R., Kullin, B., Collins, D. A., Putsathit, P., Kiratisin, P. & Riley, T. V., 29 May 2019, In : Emerging Microbes and Infections. 8, 1, p. 796-807 12 p.

Research output: Contribution to journalArticle

Open Access

Projects 1997 2017